Tran Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,075
Closed -$277K 44
2018
Q4
$277K Hold
2,075
0.05% 40
2018
Q3
$395K Sell
2,075
-144,535
-99% -$26.6M 0.05% 30
2018
Q2
$24.4M Sell
146,610
-17,709
-11% -$2.84M 3.27% 17
2018
Q1
$27.7M Buy
164,319
+4,767
+3% +$800K 3.59% 16
2017
Q4
$26.1M Sell
159,552
-42,321
-21% -$7.59M 2.48% 17
2017
Q3
$41.4M Buy
201,873
+18,678
+10% +$4.34M 3.71% 8
2017
Q2
$44.5M Sell
183,195
-46,047
-20% -$10.8M 4.01% 8
2017
Q1
$54.8M Sell
229,242
-71,636
-24% -$16.7M 4.4% 8
2016
Q4
$63.2M Sell
300,878
-172,135
-36% -$35.7M 3.86% 15
2016
Q3
$109M Sell
473,013
-115,102
-20% -$28.1M 4.45% 13
2016
Q2
$136M Buy
588,115
+505,346
+611% +$117M 4.61% 14
2016
Q1
$22.2M Buy
+82,769
New +$23.7M 0.67% 18

Other funds holding AGN

Tran Capital Management's AGN Position: Q1 2019 in Review

Tran Capital Management sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 2,075 shares — an estimated $277K sold.

Tran Capital Management first reported a position in AGN in Q1 2016 and held it in 12 quarters. The position peaked at $136M in Q2 2016. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Tran Capital Management reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Tran Capital Management sold 2,075 Allergan plc shares in Q1 2019, an estimated $277K.
  • Tran Capital Management first reported a position in Allergan plc in Q1 2016 and held it in 12 quarters.
  • Tran Capital Management's Allergan plc position peaked at $136M in Q2 2016.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Tran Capital Management's 13F filing for Q1 2019, filed 15 May 2019.